Universe Pharmaceuticals (UPC) Other Non-Current Liabilities (2022)
Historic Other Non-Current Liabilities for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $2439.5 billion.
- Universe Pharmaceuticals' Other Non-Current Liabilities changed 0.0% to $2439.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2439.5 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $2439.5 billion for FY2025, which is 0.0% changed from last year.
- Universe Pharmaceuticals' Other Non-Current Liabilities amounted to $2439.5 billion in Q3 2025, which was down 0.0% from $2439.5 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Other Non-Current Liabilities' 5-year high stood at $2439.5 billion during Q3 2024, with a 5-year trough of $2.4 million in Q3 2021.
- Moreover, its 5-year median value for Other Non-Current Liabilities was $2.4 million (2021), whereas its average is $609.9 billion.
- In the last 5 years, Universe Pharmaceuticals' Other Non-Current Liabilities crashed by 9999.99% in 2021 and then surged by 9999990000.0% in 2024.
- Universe Pharmaceuticals' Other Non-Current Liabilities (Quarter) stood at $2.4 million in 2021, then changed by 0.0% to $2.4 million in 2022, then changed by 0.0% to $2.4 million in 2023, then soared by 99999900.0% to $2439.5 billion in 2024, then changed by 0.0% to $2439.5 billion in 2025.
- Its Other Non-Current Liabilities was $2439.5 billion in Q3 2025, compared to $2439.5 billion in Q3 2024 and $2.4 million in Q1 2024.